Literature DB >> 22244740

The cystine-glutamate transporter enhancer N-acetyl-L-cysteine attenuates cocaine-induced changes in striatal dopamine but not self-administration in squirrel monkeys.

Rayna M Bauzo1, Heather L Kimmel, Leonard L Howell.   

Abstract

Extrasynaptic glutamate has been shown to regulate dopamine function in the mesocorticolimbic pathway, which plays an important role in the behavioral pharmacology of psychostimulants. Basal levels of glutamate are primarily regulated by the cystine-glutamate transporter and provide glutamatergic tone on extrasynaptic glutamate receptors. The present study examined the effects of a cystine-glutamate transporter enhancer on the neurochemical and behavioral effects of cocaine and amphetamine in nonhuman primates. It was hypothesized that augmenting extrasynaptic glutamate release with N-acetyl-L-cysteine (NAC), a cystine prodrug, would attenuate cocaine- or amphetamine-induced increases in extracellular dopamine and their corresponding behavioral-stimulant and reinforcing effects. In vivo microdialysis was used to evaluate cocaine-induced changes in extracellular dopamine (DA) in the caudate nucleus (n=3). NAC significantly attenuated cocaine-induced increases in dopamine but had inconsistent effects on amphetamine-induced increases in dopamine (n=4). Separate groups of subjects were either trained on a fixed-interval schedule of stimulus termination (n=6) or on a second-order schedule of self-administration (n=5) to characterize the behavioral-stimulant and reinforcing effects of psychostimulants, respectively. Systemic administration of NAC did not alter the behavioral-stimulant effects of either cocaine or amphetamine. Furthermore, cocaine self-administration and reinstatement of previously extinguished cocaine self-administration were not altered by pretreatment with NAC. Hence, drug interactions on caudate neurochemistry in vivo were not reflected in behavioral measures in squirrel monkeys. The present results in nonhuman primates do not support the use of NAC as a pharmacotherapy for cocaine abuse, although rodent and clinical studies suggest otherwise. Copyright Â
© 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22244740      PMCID: PMC3288731          DOI: 10.1016/j.pbb.2011.12.018

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  26 in total

1.  Repeated cocaine administration into the rat ventral tegmental area produces behavioral sensitization to a systemic cocaine challenge.

Authors:  J L Cornish; P W Kalivas
Journal:  Behav Brain Res       Date:  2001-11-29       Impact factor: 3.332

2.  Prefrontal glutamate release into the core of the nucleus accumbens mediates cocaine-induced reinstatement of drug-seeking behavior.

Authors:  Krista McFarland; Christopher C Lapish; Peter W Kalivas
Journal:  J Neurosci       Date:  2003-04-15       Impact factor: 6.167

3.  Neuroadaptations in cystine-glutamate exchange underlie cocaine relapse.

Authors:  David A Baker; Krista McFarland; Russell W Lake; Hui Shen; Xing-Chun Tang; Shigenobu Toda; Peter W Kalivas
Journal:  Nat Neurosci       Date:  2003-07       Impact factor: 24.884

Review 4.  Anatomical substrates for glutamate-dopamine interactions: evidence for specificity of connections and extrasynaptic actions.

Authors:  Susan R Sesack; David B Carr; Natalia Omelchenko; Aline Pinto
Journal:  Ann N Y Acad Sci       Date:  2003-11       Impact factor: 5.691

Review 5.  Elevated levels of GluR1 in the midbrain: a trigger for sensitization to drugs of abuse?

Authors:  William A Carlezon; Eric J Nestler
Journal:  Trends Neurosci       Date:  2002-12       Impact factor: 13.837

6.  The origin and neuronal function of in vivo nonsynaptic glutamate.

Authors:  David A Baker; Zheng-Xiong Xi; Hui Shen; Chad J Swanson; Peter W Kalivas
Journal:  J Neurosci       Date:  2002-10-15       Impact factor: 6.167

7.  Cystine/glutamate exchange serves as the source for extracellular glutamate: modifications by repeated cocaine administration.

Authors:  D A Baker; H Shen; P W Kalivas
Journal:  Amino Acids       Date:  2002       Impact factor: 3.520

8.  Serotonergic attenuation of the reinforcing and neurochemical effects of cocaine in squirrel monkeys.

Authors:  Paul W Czoty; Brett C Ginsburg; Leonard L Howell
Journal:  J Pharmacol Exp Ther       Date:  2002-03       Impact factor: 4.030

9.  Cocaine-induced changes in extracellular dopamine determined by microdialysis in awake squirrel monkeys.

Authors:  P W Czoty; J B Justice; L L Howell
Journal:  Psychopharmacology (Berl)       Date:  2000-02       Impact factor: 4.530

10.  Visualising the activity of the cystine-glutamate antiporter in glial cells using antibodies to aminoadipic acid, a selectively transported substrate.

Authors:  D V Pow
Journal:  Glia       Date:  2001-04-01       Impact factor: 7.452

View more
  8 in total

1.  Comparative Effects of Hydrogen Sulfide-Releasing Compounds on [3H]D-Aspartate Release from Bovine Isolated Retinae.

Authors:  Pratik Bankhele; Ankita Salvi; Jamal Jamil; Fatou Njie-Mbye; Sunny Ohia; Catherine A Opere
Journal:  Neurochem Res       Date:  2018-01-20       Impact factor: 3.996

2.  Effects of chronic cocaine self-administration and N-acetylcysteine on learning, cognitive flexibility, and reinstatement in nonhuman primates.

Authors:  Brian D Kangas; Rachel J Doyle; Stephen J Kohut; Jack Bergman; Marc J Kaufman
Journal:  Psychopharmacology (Berl)       Date:  2019-03-15       Impact factor: 4.530

3.  Effects of pharmacologic dopamine β-hydroxylase inhibition on cocaine-induced reinstatement and dopamine neurochemistry in squirrel monkeys.

Authors:  Debra A Cooper; Heather L Kimmel; Daniel F Manvich; Karl T Schmidt; David Weinshenker; Leonard L Howell
Journal:  J Pharmacol Exp Ther       Date:  2014-05-09       Impact factor: 4.030

Review 4.  r

Authors:  Jacqueline S Womersley; Danyelle M Townsend; Peter W Kalivas; Joachim D Uys
Journal:  Eur J Neurosci       Date:  2018-09-24       Impact factor: 3.386

Review 5.  The reinstatement model of drug relapse: recent neurobiological findings, emerging research topics, and translational research.

Authors:  Jennifer M Bossert; Nathan J Marchant; Donna J Calu; Yavin Shaham
Journal:  Psychopharmacology (Berl)       Date:  2013-05-18       Impact factor: 4.530

6.  Hypothesizing Balancing Endorphinergic and Glutaminergic Systems to Treat and Prevent Relapse to Reward Deficiency Behaviors: Coupling D-Phenylalanine and N-Acetyl-L-Cysteine (NAC) as a Novel Therapeutic Modality.

Authors:  Kenneth Blum; Marcelo Febo; Claudia Fahlke; Trevor Archer; U Berggren; Zsolt Demetrovics; Kristina Dushaj; Rajendra D Badgaiyan
Journal:  Clin Med Rev Case Rep       Date:  2015-12-17

7.  The down-regulation of SLC7A11 enhances ROS induced P-gp over-expression and drug resistance in MCF-7 breast cancer cells.

Authors:  Chun Ge; Bei Cao; Dong Feng; Fang Zhou; Jingwei Zhang; Na Yang; Siqi Feng; Guangji Wang; Jiye Aa
Journal:  Sci Rep       Date:  2017-06-19       Impact factor: 4.379

Review 8.  N-acetylcysteine in substance use disorder: a lesson from preclinical and clinical research.

Authors:  Irena Smaga; Małgorzata Frankowska; Małgorzata Filip
Journal:  Pharmacol Rep       Date:  2021-06-06       Impact factor: 3.024

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.